New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
14:51 EDTBCRXBioCryst price target raised to $17 from $13 at JMP Securities
JMP Securities raised BioCryst's price target to $17 following proof of concept results for OPuS-1 Phase 2a trial. Shares are Outperform rated.
News For BCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
10:00 EDTBCRXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:01 EDTBCRXBioCryst upgraded to Neutral from Underperform at BofA/Merrill
Subscribe for More Information
06:36 EDTBCRXBioCryst upgraded to Neutral from Underperform at BofA/Merrill
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use